πŸ‡ΊπŸ‡Έ FDA
Patent

US 6171596

Oligomeric HIV-1 envelope glycoproteins

expired A61KA61K2039/5256A61K2039/54

Quick answer

US patent 6171596 (Oligomeric HIV-1 envelope glycoproteins) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Jan 09 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/5256, A61K2039/54, A61K2039/545, A61K2039/55566